methyldopa 500mg tablets
sigma pharmaceuticals plc - methyldopa (anhydrous) - oral tablet - 500mg
methyldopa 250mg tablets
ennogen pharma ltd - methyldopa (anhydrous) - oral tablet - 250mg
methyldopa 500mg tablets
ennogen pharma ltd - methyldopa (anhydrous) - oral tablet - 500mg
methyldopa 125mg tablets
ennogen pharma ltd - methyldopa (anhydrous) - oral tablet - 125mg
methyldopate hydrochloride injection solution
american regent, inc. - methyldopate hydrochloride (unii: 7px435dn5a) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopate hydrochloride 50 mg in 1 ml
methyldopa tablet, film coated
chartwell rx, llc - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa is contraindicated in patients: — with active hepatic disease, such as acute hepatitis and active cirrhosis — with liver disorders previously associated with methyldopa therapy ( see warnings ) — with hypersensitivity to any component of these products. — on therapy with monoamine oxidase (mao) inhibitors.
methyldopa 500mg tablets
mawdsley-brooks & company ltd - methyldopa (anhydrous) - oral tablet - 500mg
methyldopa 500mg tablets
a a h pharmaceuticals ltd - methyldopa (anhydrous) - oral tablet - 500mg
methyldopa 500mg tablets
the boots company plc - methyldopa (anhydrous) - oral tablet - 500mg
methyldopa 500mg tablets
c p pharmaceuticals ltd - methyldopa (anhydrous) - oral tablet - 500mg